Prevalence and antibiotics susceptibility profiles of Streptococcus pyogenes among pediatric patients with acute pharyngitis at Felege Hiwot Comprehensive Specialized Hospital, Northwest Ethiopia (2024)

As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsem*nt of, or agreement with, the contents by NLM or the National Institutes of Health.
Learn more: PMC Disclaimer | PMC Copyright Notice

Prevalence and antibiotics susceptibility profiles of Streptococcus pyogenes among pediatric patients with acute pharyngitis at Felege Hiwot Comprehensive Specialized Hospital, Northwest Ethiopia (1)

Link to Publisher's site

BMC Microbiol. 2021; 21: 135.

Published online 2021 May 3. doi:10.1186/s12866-021-02196-0

PMCID: PMC8091706

PMID: 33941090

Author information Article notes Copyright and License information PMC Disclaimer

Associated Data

Data Availability Statement

Abstract

Background

Streptococcus pyogenes (S. pyogenes) is a Gram positive bacterium which is a leading cause of pharyngitis, skin and soft tissue infection and post streptococcal syndromes. Due to lack of β-lactamase enzyme production, it was considered universally susceptible to penicillin group and later generation of β-lactam antibiotics. As such, empirical treatment was common which might leads to development of antibiotics resistance. Therefore, the aims of this study were to determine the prevalence, antibiotics susceptibility profile; and associated factors of S. pyogenes among pediatric patients with acute pharyngitis in Felege Hiwot Comprehensive Specialized Hospital (FHCSH), Northwest Ethiopia.

Methods

Hospital based cross-sectional study was carried out on 154 pediatric patients, whose age ranged from 0 to 18 years old using consecutive convenient sampling technique from 1st February to 19th June 2020 at FHCSH. S. pyogenes were identified by throat swab culture on 5% sheep blood agar with an overnight incubation at 37 °C in candle jar containing 5% CO2. Gram stain, catalase test and bacitracin test were used to identify S. pyogenes. Then,the data were entered into EpiData version 3.1 and analyzed by SPSS version 20 software. Finally, stepwise,bivariable and multivariable logistic regressions were carried out for identifyying factors having significant ssociation (p<0.05)with acutepharyngitis.

Results

From the total throat swabs, 14 (9.1%) with (95% CI; 4.5–14.3) were culture positive for S. pyogenes. From these, all isolates were sensitive to penicillin and ampicillin. On the otherhand, 4 (35.7%), 4 (35.5%), 3 (21.4%), 2 (14.3%), 1 (7.1%), 7 (50.0%) and 1 (7.1%) isolateswere resistant for ceftriaxone, vancomycin, erythromycin, tetracycline, chloramphenicol, clindamycin and levofloxacin, respectively. The presence of any smoker in home showed significant association with S. pyogenes acute pharyngitis. Furthermore, having tender lymphadenopathy and recurrence were clinical predictors for S. pyogenes acute pharyngitis (P < 0.05).

Conclusion

The prevalence of S. pyogenes was guaged at9.1% which is considered as low prevalence. All S. pyogenes isolatsremain sensitive to penicillin. However, resistance was reported to clindamycin 7 (50.0%), ceftriaxone 5 (35.7%) and erythromycin 3 (21.4%). The current practice of giving erythromycin, clindamycin instead of penicillin and ampicillin is againest the microbiology result. Therefore, current empirical treatment of acute pharyngitis shall take in to account the current evidences. Continuous surveillance of antibiotics resistance pattern of S. pyogenes for acute pharyngitis must be strengthen to improve the use of antibiotics in hospitals.

Keywords: Prevalence, S. pyogenes, Pediatrics, Acute pharyngitis, Antibiotics susceptibility test

Background

Streptococcus pyogenes (S. pyogenes) is a Gram positive, extracellular, spherical shape and β-hemolytic bacterium which can grow on enrichment culture media [1]. It was identified as the cause of erysipelas in 1883 by Friedrich Fehleisen [2]. However, in 1933, Rebecca Lancefield made serologic classification of Group A Streptococcus (GAS) based on group A carbohydrate that composed of N-acetyl glucosamine linked to S. pyogenes cell wall antigens as rhamnose polymer backbone. As the result, GAS was named as S. pyogenes [3].

S. pyogenes were responsible for several clinical conditions such as scarlet fever, acute rheumatic fever, glomerulonephritis, sepsis, necrotizing fasciitis, meningitis, streptococcal toxic shock syndrome, impetigo and acute pharyngitis [4]. Acute pharyngitis is one ofthe disease caused by S. pyogenes. It is an inflammation of oropharynx mucous membranes or posterior pharynx and tonsils [5] with different clinical manifestations such as sore throat, sudden onset fever, red pharynx, enlarged tonsils, yellow or blood-tinged exudates, petechiae on the soft palate and posterior pharynx [6].

About hundred millions people develop serious S. pyogenes infection every year. Itcause about 660,000 invasive infections and 616 million cases of pharyngitis that result in 163,000 death from 2009 to 2014 [7]. In African countries, S. pyogenes was isolated from children with acute pharyngitis and the its'prevalence was as high as 66.7, 28, 2.3, and 11.3% in Nigeria [8], Egypt [9], Kenya [10] and Jimma, Ethiopia [11], respectively.

S.yogentransmission can be through direct contact, contaminated fomites, or food borne contamination or droplets from those with pharyngeal infection or colonization [12]. Most S. pyogenes infections were treated with penicillin andstill being effectively used for empricaltreatment [13]. However, those patients with allergic to penicillin have been treated with erythromycin, amoxicillin, cotrimoxazole, chloramphenicol, tetracycline, azithromycin and clindamycin [14]. Hence, current treatment guidelines discourage the empirical use of antibiotics due to unnecessary antibiotic exposure and drug resistance [15]. Additionally, due to lack of β-lactamase enzyme production by S. pyogenes, it was considered universally susceptible to penicillin group and later generation of β-lactam antibiotics. Even though, early untreated S. pyogenes acute pharyngitis leads to post infection complications such as acute rheumatic fever (ARF) and rheumatic heart disease (RHD) and glomerulonephritis [16].

There is not much information on the screening of children for carriage of S. pyogenes in Ethiopia [17] but empirical treatment is the current practice in the study area and at large in Ethiopia. Additionally, people do not complete their treatment or took irregularly. Even though all these practices might contribute for drug resistance emergency in the study area, the study on ` prevalence, AST and associated factors of S. pyogenes acute pharyngitis among pediatric patients was not done in Amhara region, Bahir Bar. Additionally, empirical treatment is common on acute pharyngitis without any laboratory identificationof real pathogens. However, the clinical predictors of acute phayngitiswere variable acrossgeographical regions. Therefore, this study aimed to determine the prevalence, antibiotics susceptibility profiles and associated factors of S. pyogenes among pediatric patients with acute pharyngitis in FHCSH, Bahir Dar, Northwest Ethiopia.

Methods

Study design, period, area and population

Hospital based cross-sectional study was carried out from 1st February to 19th June 2020 at FHCSH in Bahir Dar, Ethiopia.. In FHCSH, there was 121 empirically treated acute pharyngitis cases in the last February to may, 2019 [18]. Padiatric patients attending to FHCSH with acute pharyngitis were the study population.

Inclusion and exclusion criteria

All children with age ≤ 18 years and with symptoms of acute pharyngitis at FHCSH were included to this study. Whereas, those who took antibiotics within 2 weeks of sample collection were excluded in this study.

Sample size determination and sampling technique

The sample size was calculated using a single population proportion formula based on the assumption of 5% expected margins of error, 95% confidence interval (Za/2 = 1.96) or alpha (α = 5%) and 11.3% prevalence based on a studyin Jimma town, Ethiopia [11].

N=Za/22×P1Pd2=1.962×0.11310.1130.052=154,

where p- prevalence

d- margin of error

N- Number of sample size

Thus, a total 154 throat samples were collected by consecutive convenient sampling technique.

Data collection and processing

The data were collected by trained pediatric nurses and principal investigator. Thus, sociodemographic, environmental factors, behavioral and housing relateddata were collected by structured pre-tested Amharic version questionnaire using face to face interview with parents/ guardians. Participants whose age < 15 were interviewed via their gurdianand participants whose age > 15 years were interviewed directly after obtaining assent. Clinical data were collected by trained pediatric nurses. At each data collection spot, sufficient explanation about the aim of the research was given to the parents or study participants before conducting theinterview.

Sample collection and transportation

A single throat swab specimen was collected on the tonsils and the posterior pharynx from each study participants for culture using sterile cotton swab. The specimen could be collected at symptomatic area at which cotton swab rolled three times on exudates, inflamed pharynx, and swollen tonsil. Tongue depressor was used to depress tongue during throat swab collection [19]. Then, these throat swabs were transported using Amie’s transport media with cold box containing ice pack to Bahir Dar University, Microbiology Research Laboratory Center.

Streptococcus pyogenes identification

Throat swabs were inoculated on 5% sheep blood agar plates and incubated at 37 °C in candle jar with 5% CO2 atmosphere for 24 h [2022]. Catalase test was done from 24 h growth of β-hemolytic colonies to differentiate catalase negative Streptococcus species. This catalase negative Streptococcus species was subjected to bacitracin test. As such, colony suspension with normal saline matched with 0.5 McFarland standards was prepared from fresh 24 h growth of colonies and inoculated on 5% sheep blood agar. Then, imidiately placed bacitracin disk. Finally,, any inhibition was showed as bacitracin sensitive for S. pyogenes [20] after 24 h incubation at 37 °C in candle jar [19].

Antibiotic susceptibility test

Antimicrobial susceptibility test (AST) was done by disk diffusion method on Mueller-Hinton (MHA) agar supplemented with 5% sheep blood [20]. Suspension was prepared from 3 to 5 pure S. pyogenes colonies mixed with 5 ml normal saline in sterile glass test tube which matched with 0.5 McFarland standards. Such suspension was evenly spread onto Mueller Hinton agar supplemented with 5% sheep blood using sterile cotton swab. The tested antibiotics included penicillin (P= 10 U), ampicillin (AMP = 10 μg), erythromycin (E = 15 μg), chloramphenicol (C= 30 μg), clindamycin (DA = 2 μg), tetracycline (TE = 30 μg), vancomycin (VA = 30 μg), levofloxacin (LEF = 5 μg), ceftriaxone (CRO = 30 μg), cefotaxime (CTX = 30 μg), Collect cefepime (FEP = 30 μg). After inoculation, it was incubated at 37Oc in a candle jar for over 18 h. After then, zone of inhibition was measured with ruler and interpreted as sensitive, intermediate and resistant according to the principles established by CLSI M100 guideline [20].

Quality control

The structured questionnaires were prepared in English and translated into Amharic language and then back translated to English to check inconsistencies of meaning of words. About 5% of structured questionnaire was pretested in Shegaw Motta General Hospital and training was also provided to pediatric nurse how to collect the data.

After throat swab samples were collected aseptically, transportation was carried out using Amies transport medium [22] to Bahir Dar university Microbiology Resaerch Laboratory Center by maintaining cold chain, or cold box with dry ice [23]. Theculture media was prepared aseptically by autoclaving and the sterlitywas checked by incubating5% of the batch prepared media overnight. Additionally, the performance of themedia was checked for growth of known Streptococcus pneumoniae (S. pneumoniae) ATCC 49619 as a positive control [20]. Likewise, Bacitracin test was checked by Streptococcus pyogene ATCC 19615 as positive and Streptococcus agalactiae ATCC 13813 as negative control.

Data analysis

Data was entered by EpiData version 3.1 and data analysis was performed using SPSS version 20. The prevalence of S. pyogenes and antibiotics resistance was determined by descriptive statistics. Multivariable logistic regression was done by entering the variables with p < 0.2 in bivariable logistic regression to identify the associated factor and clinical predictors. AP value<0.05 consideredas statistically significant association in the multivariate logistic regression.

Ethical consideration

The studyapproved byCollege of Medicine and Health Science, Bahir Dar University’s Research Institutional Review Board with reference number CMHS 0014/2020 and a permission letter was obtained from FHCSH. The purpose and importance of the study was explained to the participants. Written informed consent from parent/guardian and assent from children was obtained in accordance with the Declaration of Helsinki. Additionally, absence of link between the study and their service was explained and participation was entirely voluntary based. Furthermore, the confidentiality of study participant was kept and identification of study participant by name was avoided.

Results

Sociodemographic characteristics of study participants

A total of 154 pediatric children were recruited to this study. From those, the majority 81 (52.6%) of participants were females and 73 (47.4%) were males. Study participant’s age were ranged from 0 to 18 years old with mean age 8.483, median 9.0 and standard deviation (SD = 4.8). Majority of study participants were less than 5 years age 51 (33.1%) followed by 5–10 years of age 46 (29.9%) and 10-15 years of age43 (27.9%). Moreover, about 102 (66.2%) participants were from urban. Additionally, the majority 65 (42.1%) of participants could not able to read & write (Table1).

Table 1

Prevalence of S. pyogenes with respect to socio-demographic characteristics among pediatric patient with acute pharyngitis in FHCSH, Northwest Ethiopia, 1st February to 19th June 2020

VariablesCategoriesCulture result for S. pyogenesTotal
N (%)
Positive
N (%)
Negative
N (%)
SexMale3 (2.0)70 (45.45)73 (47.45)
Female11 (7.1)70 (45.45)81 (52.55)
Age (in year)< 50 (0)51 (33.1)51 (33.1)
5–98 (5.2)38 (24.7)46 (29.9)
10–145 (3.2)38 (24.7)43 (27.9)
15–181 (0.7)13 (8.4)14 (9.1)
ResidenceUrban9 (5.9)93 (60.4)102 (66.3)
Rural5 (3.2)47 (30.5)52 (33.7)
Education level of childrenCannot read &write5 (3.2)60 (39.1)65 (42.2)
Can read & write0 (0)7 (4.7)7 (4.7)
Primary school8 (5.2)56 (34.4)64 (41.6)
Secondary school1 (0.6)16 (10.3)17 (10.9)
College and above0 (0)1 (0.6)1 (0.6)
Occupation of parents/guardiansHouse wife4 (2.65)42 (27.3)46 (29.95)
Farmer4 (2.65)33 (21.4)37 (24.05)
Merchant3 (1.9)29 (18.8)32 (20.7)
Laborer0 (0)8 (5.2)8 (5.2)
Employed3 (1.9)28 (18.2)31 (20.1)
Total14 (9.1)140 (90.9)154 (100)

N: Frequency, % :Percent

Prevalence of Streptococcus pyogenes

The overall prevalence of S. pyogenes was 14 (9.1%; 95%; CI = 4.5–14.3). Out of the total S. pyogenes culture positives with acute pharyngitis, females shared 11 (7.1%). According to age categories, there was no positive for S. pyogenes in the age less than 5 years. Whereas 8 (5.2%), 5 (3.2%) and 1 (0.7%) were age between 5 and 10, 10–15 and 15–18, respectively. Furthermore, about 8 (5.2%) S. pyogenes isolateswere isolated from those participants in primary school. The isolation rates of S. pyogenes with different socio-demographic characteristics were summarized (Table (Table11).

Antibiotics susceptibility profiles of Streptococcus pyogenes

Different antibiotics classes were used for determining susceptibility profile of S. pyogenes isolates. As the result, all isolates of S. pyogenes were sensitive for both penicillin and ampicillin. Furthermore, the proportions of antibiotics resistances to clindamycin, ceftriaxone, cefotaxime, cefepime, vancomycin, erythromycin, tetracycline and chloramphenicol were 7 (50.0%), 5 (35.7%), 3 (21.4%), 2 (14.3%), 5 (35.7%), 3 (21.4%), 2 (14.3%) and 1 (7.1%), respectively. However, clindamycin 1 (7.1%), erythromycin 2 (14.3%), tetracycline 2 (14.3%) and chloramphenicol 2 (14.3%) were intermediate findings (Fig.1).

Prevalence and antibiotics susceptibility profiles of Streptococcus pyogenes among pediatric patients with acute pharyngitis at Felege Hiwot Comprehensive Specialized Hospital, Northwest Ethiopia (3)

Antibiotic susceptibility profile of S. pyogenes isolates among pediatric patient with acute pharyngitis in FHCSH from 1st February to 19th June 2020

Out of the total 14 S. pyogene isolates, the proportion of multidrug resistant isolateswere 3(21.3%). From which, 1(7.1%) was multi drug resistance for erythromycin, clindamycin and vancomycin but 1(7.1%) for erythromycin, tetracycline and vancomycin. The rest 1(7.1%) was multidrug resistant for chloramphenicol, Cephame group and levofloxacin simultaneously.

Factors associated with Streptococcus pyogenes acute pharyngitis

In univariables analysis, variables having a P-value of < 0.2 was entered in to multivariable logistic regression analysis. Based on this, sex, number of bed shared in home, frequency ofcold drink, presence of smoker in home, separate kitchen and malnutrition were selected by forward likelihood logistic regression method. After adjusting other confounding variables, the pediatric children living with in the presence of any smokers in home showed 7.11 times more likely to develop S. pyogenes acute pharyngitis than those live in absence of any smokers in hone (AOR = 7.11, CI =1.694–29.82, P = 0.02) (Table2).

Table 2

Bivariable and multivariable logistic regression analysis of factors associated with S. pyogenes acute pharyngitis in FHCSH, Northwest Ethiopia, 1st February to 19th June 2020

VariablesCategoriesS. pyogenesCOR(95%CI) P- valueAOR(95%CI)P- value
Pos (N)Neg (N)
Family number in home> 5137511.2 (1.4–88.5)0.021*
< 51651
SexMale3701
Female11703.66 (2.98–13.71) 0.054*
Age (in year)<  50513.92 (1.24–67.0) 0.35
5–108381.42 (1.05–3.72) 0.434
10–155381.59 (1.06–5.450) 0.63
> 151131
ResidenceUrban9931
Rural5471.09 (0.35–3.47) 0.872
Number of bed shared in home> 22726.35 (1.37–29.43) 0.018*
< 212681
Frequently cold DrinkYes8413.22 (1.05–9.86) 0.041*
No6991
Passive SmokerYes8304.89 (1.57–15.18) 0.006*7.11 (1.69–29.82)0.01**
No611011
Active smokeryes1232.56 (1.32–20.51) 0.38
No131171
Separate kitchenYes3731.07 (1.01–3.55) 0.012*2.05 (1.21–5.45) 0.16
No116711
MalnutritionYes142.12 (1.07–19.10) 0.06*
No13136

N Frequency, COR Crude odd Ratio, AOR Adjusted Odd Ratio, Pos Positive, Neg Negative, * = variable enrolled to multivariate regression (P- value < 0.2), ** = statistical significant

According to clinical predictors, all variables having aP-value< 0.2 in the bivariable was also subjected to multivariable analysis. Hence, the presence of tender lymphadenopathy were 14.45 times more likely to be S. pyogenes acute pharyngitis compared to those did not have tender lymphadenopathy (AOR = 14.45, 95% CI =1.6–30.3, P = 0.03). Similarly, the pediatric patients with history ofrecurrence were 5.87 time more likely to be acute pharyngitis caused by S. pyogenes compared to those did not having recurrence (AOR = 5.87, 95% CI = 1.63–12.31, P = 0.02). Therefore, tender lymphadenopathy and history of clinicalrecurrence (P < 0.05) were found to be independent predictors for S. pyogenes acute pharyngitis in pediatrics (Table3).

Table 3

Bivariable and multivariable logistics regression analysis of chief clinical variables for S. pyogenes acute pharyngitis in FHCSH, Northwest Ethiopia, 1st February to 19th June 2020

VariablesCategoryS. pyogenesCOR (95%CI) P valueAOR (95%CI) P value
Pos (N)Neg (N)
Body temperature (In o C)>  384312.41 (1.41–8.79) 0.57
< 38101091
Painful throatYes131212.04 (1.25–16.51) 0.50
No1191
HeadacheYes6651.16 (1.08–3.50) 0.79
No8751
VomitingYes2331.85 (1.94–8.69) 0.44
No121071
Abdominal painYes1181.92 (1.24–15.56) 0.54
No131221
Enlarged tonsilYes8751.86 (1.38–3.50) 0.80
No6651
RecurrenceYes11545.84 (1.56–21.87) 0.01*5.87 (1.89–26.78) 0.02**
No38611
Inflame pharynxYes9871.10 (1.349–3.45) 0.88
No5531
Pharyngeal ExudateYes12844.0 (1.86–18.56) 0.08*
No2561
LymphadenopathyYes13711.83 (1.6–5.56) 0.029*14.45 (1.6–30.3) 0.02**
No16911
Scarlatiniform RashYes104112.6 (1.61–99.2) 0.02*
No4991
DysphagiaYes10791.93 (1.58–6.45) 0.29
No4611
Running noseYes2251.3 (1.28–6.20) 0.74
No121151

N frequency, COR Crude odd Ratio, AOR Adjusted Odd Ratio, Pos Positive, Neg Negative, * = variable entered to multivariate regression (P- value < 0.2), ** = statistical significant

Discussion

Streptococcus pyogenes infection among the pediatric group is a cause of acute pharyngitis which could leads morbidity and mortality [24]. Pediatric patients with acute pharyngitis require microbiologic investigation and proper treatment to abort complications [25]. A totals of 154 throat swab sampleswere analyzed in the present study.Our 95% CI (4.5–14.3)used to clasfiedstudies in to low and high prevalence. For instance, prevalence studies with< 4.5% were considered as lower, and prevalence studies with > 14.3% is considered ashigher findings and findings in between 95% CI of our study were considered asin agreement with current study.

Accordingly, the prevalence of S. pyogenes 14(9.1%) in the current study which is comparable with the previous conducted in Jimma, Ethiopia 11.3% [11], India 5.5% [16], Japan 5.8% [26], Indonesia 13.5% [27] and Nepal 9.2% [28]. But it was higher than a study from Mexico 0.04–0.42% [29], Brazil 3.9% [30], Romania 4% [31], Iran2.5% [32] and Saudi Arabia 1.5% [33]. This high prevalence rate in our study might be due seasonal nature of S. pyogenes incidence which is higher from February to May [11]. Additional reason for the difference might be sample size and method variation. In the contrary, the proportion of the recent study 9.1% was much lower than findings from USA 28.6–37% [34, 35] and 16–45% in African [3639], Iran 30% [40] and Israel 69.5% [41]. Such variation could be attributed to difference geography, method, socio-economic conditions, and sample size.

Based on antibiotics susceptibility profiles in the present study, all isolates were sensitive to penicillin which is in agreement with studies reported in USA [29, 30], Asia [16, 42, 43], Europe [41, 44, 45], African countries including Egypt [46], Kenya [39] and Jima, Ethiopia [11]. This might be due to lack of β-lactamase production by S. pyogenes. Even though, penicillin resistance for S. pyogenes may happen by escaping penicillin treatment by entering epithelial cells, which are poorly penetrated by penicillin [47], by forming a biofilm [48] and protection of S. pyogenes by other β-lactamase-producing bacterial species [49, 50].

In accordance to other antibiotic resistance, simple comparison of resistance percentage was done comparatively, which was statistically higher or lower than those reported in the previous studies. Hence, it is known that erythromycin and clindamycin are usually used as an alternative treatment for patients allergic to penicillin. However, in the current study, erythromycin (21.4%) and clindamycin (50%) resistance were recorded which was higher than no resistant to erythromycin and clindamycin reported in Jimma, Ethiopia [11], erythromycin (10.6%) in Spain [45] but much lower than 64–83% resistance to erythromycin in India [43, 51]. Similarly, 35.7, 21.4 and 14.3% resistance to ceftriaxone, cefotaxime and cefepime were reported in our study which was higher than no resistance for ceftriaxone and cefotaxime in Pakistan [42] and India [16, 43] and Ethiopia [11], respectively. This variation might be due to physician provided treatment of non β-lactam drugs for acute pharyngitis case by considering Gram negative bacteria empirically. This might be the leading cause a high rate cephalosporin and erythromycin resistance. Additionally, erythromycin resistance in S. pyogenes occurs via target site modification that erythromycin ribosomal methylase (erm) genes encode an enzyme that methylate a single adenine in 23S rRNA and results conformational change in the ribosome, leading to reduced binding of erythromycin and clindamycin [52]. Similarly, in target drug efflux, mefA (macrolide efflux pump) genes encode an efflux pump of 14- and 15-carbonring macrolides, conferring resistance to erythromycin only. Furthermore, tetracycline resistance is conferred by ribosome protection genes such as tet(M) or tet(O) and efflux pumps for tetracycline encoded by the tet(K) or tet(L) gene also confer tetracycline resistance [53]. The erm and mefA genes are often collocated with tet gene of S. pyogenes strains are resistant to both macrolides and tetracycline [54].

According to factors in the current study, presence of any smokers in home (P value < 0.05) was associated with S. pyogenes acute pharyngitis in pediatric patients. This result was in agreement with previous finding reported in Northern India [44]. This might be due to presence of any smoker in home leads to children inhaled smokes which kills normal flora that able to compete pathogen from adherence, altered bacterial acquisition and make oral mucosal colonization in favor of S. pyogenes periodontal pathogens. Furthermore, the presence tender lymphadenopathy and recurrence (P value< 0.05) were found to be independent clinical predictors for S. pyogenes acute pharyngitis among pediatrics. Similar finding of tender lymphadenopathy and recurrences were reported in India [55], Yemen Saudi Arabia [56] and Jimma, Ethiopia [11]. However, clinical predictors varied with geographical area and immune status of study population [57].

Limitation of the study

The limitations of this study were being small sample size which might be underestimating the prevalence of S. pyogenes. Additionally, MIC or E test was not done for better evaluation of its antibiotics susceptibility profiles.

Conclusion

In this study, the prevalence of S. pyogenes in pediatric children with acute pharyngitis was 9.1%. All S. pyogenes remain sensitive to penicillin and ampicillin. The resistance rate was obtained to clindamycin 7 (50.0%), ceftriaxone 5 (35.7%), vancomycin 5 (35.7%), cefotaxime 3 (21.4%), erythromycin 3 (21.4%), cefepime 2 (14.3%) and tetracycline 2 (14.3%). The overall multidrug resistance was 21.3%. Relatively low resistance was documented to penicillin, ampicillin, levofloxacin and chloramphenicol. Hence, similar to other studies these drugs were considered as an empirical treatment for S. pyogenes acute pharyngitis in pediatric patients. The presence of any smoker in home was associated with S. pyogenes acute pharyngitis whereas tender lymphadenopathy and recurrence of sore throat were clinical predictors for S. pyogenes acute pharyngitis (p < 0.05) in our study. There should be routine throat culture and a continuous surveillance of antibiotics resistance pattern for S. pyogenes to improve the use of antibiotics in hospitals.

Acknowledgements

We would like to forward our gratitude to Bahir Dar University, College of Medicine and Health Sciences, School of Health Sciences, Department of Medical Laboratory Science for providing us the ethical clearance letter. Then we would like to acknowledge all the children, parents and FHCSH paediatric staff who cooperated with us in this study. Finally, we would like to extend our deepest gratitude for ANRSHB for its sponsor and APHI for their logistic support.

Abbreviations

ANRSHBAmhara National Regional State Health Bureau
AORAdjusted Odd Ratio
APHIAmhara Public health Institute
ARFAcute Rheumatic Fever
ASTAntibiotic Susceptibility Test
ATCCAmerican Type Culture Collection
BAPBlood agar plate
BDUBahir Dar University
CLSIClinical Laboratory of Standard Institute
CMHSCollege of Medicine and Health Science
CORCrude Odd Ratio
FHCSHFelege Hiwot Comprehensive Specialized Hospital
GASGroup A Streptococcus
IDSAInfectious Diseases Society of America
IDIndividual identity
IQCInternal Quality Control
MHAMuller-Hinton agar
MICMinimum inhibitory concentration
OPDOutpatient department
PYRPyrrolidonyl arylamidase test
RHDRheumatic heat disease
RADTRapid antigen detection test
SOPsStandard operating procedures
SPSSStatistical package for social sciences
URTIUpper respiratory tract infection
USUnited States
WHOWorld Health Organization

Authors’ contributions

Destaw Kebede: Participated on the conception, design, data collection, analysis and interpretation. Daniel Mekonnen and Alemale Admas facilitated the data collection and management, drafted, analysis and critically reviewed the manuscript. All authors read and approved of the final manuscript.

Authors’ information

Destaw Kebede is Laboratory personnel at Shegaw Motta General Hospital in Medical Microbiology. Daniel Mekonnen is an associate professor at College of Medicine and Health Sciences, Bahir Dar University in Medical Microbiology and Institute of Biotechnology, Bahir Dar University, Alemale Admas is lecturer at College of Medicine and Health Sciences, Bahir Dar University in Medical Microbiology.

Funding

Not applicable.

Availability of data and materials

The data supporting the conclusion of the study could be avaliabale upon the requestof Destaw Kebede (correspondence author; mobile + 251911594675, email: amaueldestaw@gmail.com).

Declarations

Ethics approval and consent to participate

The study was approved byCollege of Medicine and Health Science, Bahir Dar University’s research Institutional Review Board (Reference number CMHS 0014/2020) and a permission letter was also obtained from FHCSH. Additionally, informed written consents from guardians or parents and assents from each study participants were obtained in accordance with the Declaration of Helsinki. The confidentiality of study participant was kept and identification of study participant by name was avoided. Positive individuals were linked to health institution for better managements accordingly.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Footnotes

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

1. Walker MJ, Barnett TC, McArthur JD, Cole JN, Gillen CM, Henningham A, Nizet V. Disease manifestations and pathogenic mechanisms of group a Streptococcus. Clin Microbiol Rev. 2014;27(2):264–301. [PMC free article] [PubMed] [Google Scholar]

2. Ferretti J, Stevens D.& Fischetti, V. Laboratory diagnosis of Streptococcus pyogenes (group a streptococci)--Streptococcus pyogenes: Basic Biology to Clinical Manifestations. 2016. [Google Scholar]

3. Ralph AP, Carapetis JR. Group A Streptococcal Diseases and Their Global Burden. In: Chhatwal G. (eds) Host-Pathogen Interactions in Streptococcal Diseases. Current Topics in Microbiology and Immunology. Springer: Berlin, Heidelberg; 2012. p. 368. 10.1007/82_2012_280 [PubMed]

4. Sims Sanyahumbi A, Colquhoun S, Wyber R, et al. Global Disease Burden of Group A Streptococcus. In: Ferretti JJ, Stevens DL, Fischetti VA, editors. Streptococcus pyogenes : Basic Biology to Clinical Manifestations [Internet]. Oklahoma City (OK): University of Oklahoma Health Sciences Center; 2016-. Available from: https://www.ncbi.nlm.nih.gov/sites/books/NBK333415/. [PubMed]

5. Hurst JR, Kasper KJ, Sule AN, McCormick JK. Streptococcal pharyngitis and rheumatic heart disease: the superantigen hypothesis revisited. Infect Genet Evol. 2018;61:160–175. [PubMed] [Google Scholar]

6. Choby BA. Diagnosis and treatment of streptococcal pharyngitis. Am Acad Fam Phys. 2009;79(5):383–390. [PubMed] [Google Scholar]

7. Imöhl M, Fitzner C, Perniciaro S, van der Linden M. Epidemiology and distribution of 10 superantigens among invasive Streptococcus pyogenes disease in Germany from 2009 to 2014. PLoS One. 2017;12(7):e0180757. [PMC free article] [PubMed] [Google Scholar]

8. Uzodimma CC, Dedeke FI, Nwadike V, Owolabi O, Arifalo G.& Oduwole O. A study of group a streptococcal pharyngitis among 3–15-year-old children attending clinics for an acute sore throat. Niger J Cardiol. 2017;14(2):97. [Google Scholar]

9. Sultan A, Seliem W. Evaluating the use of dedicated swab for rapid antigen detection testing in group a streptococcal pharyngitis in children. Afr J Clin Exp Microbiol. 2018;19(1):24–29. [Google Scholar]

10. Osowicki J, Azzopardi KI, Baker C, Waddington CS, Pandey M, Schuster T, McCarthy JS. Controlled human infection for vaccination against Streptococcus pyogenes (CHIVAS): establishing a group a Streptococcus pharyngitis human infection study. Vaccine. 2019;37(26):3485–3494. [PubMed] [Google Scholar]

11. Tesfaw G, Kibru G, Mekonnen D, Abdissa A. Prevalence of group A β-hemolytic Streptococcus among children with pharyngitis in Jimma town, Southwest Ethiopia. Egypt J Ear, Nose, Throat Allied Sci. 2015;16(1):35–40. [Google Scholar]

12. Makthal N, VanderWal AR, Saavedra MO, Olsen RJ, Musser JM, Kumaraswami M. Environmental pH and peptide signaling control virulence of Streptococcus pyogenes via a quorum-sensing pathway. Nat Commun. 2019;10(1):1–14. [PMC free article] [PubMed] [Google Scholar]

13. Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G, Van Beneden C. Clinical practice guideline for the diagnosis and management of group a streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis. 2012;55(10):e86–e102. [PMC free article] [PubMed] [Google Scholar]

14. Behnamfar Z, Shahkarami V, Sohrabi S, Aghdam AS, Afzali H. Cost and effectiveness analysis of the diagnostic and therapeutic approaches of group a Streptococcus pharyngitis management in Iran. J Fam Med PrimCare. 2019;8(9):2942–2949. [PMC free article] [PubMed] [Google Scholar]

15. Luo R, Sickler J, Vahidnia F, Lee Y-C, Frogner B, Thompson M. Diagnosis and Management of Group a streptococcal pharyngitis in the United States, 2011–2015. BMC Infect Dis. 2019;19(1):193. [PMC free article] [PubMed] [Google Scholar]

16. Khandekar A. Tackling rheumatic heart disease: prevalence and antibiogram of Streptococcus pyogenes in cases of paediatric pharyngitis. J Clin Diagn Res. 2019;13(2):11–13. [Google Scholar]

17. Abdissa A, Asrat D, Kronvall G, sh*tu B, Achiko D, Zeidan M. … & Aseffa, A. throat carriage rate and antimicrobial susceptibility pattern of group a streptococci (GAS) in healthy Ethiopian school children. Ethiop Med J. 2011;49(2):125–130. [PubMed] [Google Scholar]

18. Fentahun N, Anteneh Y, Menber Y. Malnutrition in the Outcome of Wound Healing at Public Hospitals in Bahir Dar City, Northwest Ethiopia: A Prospective Cohort Study. J Nutr Metab. 2021;2021. [PMC free article] [PubMed]

19. World Health Organization (WHO) Guidelines for the collection of clinical specimens during field investigation of outbreaks (No. WHO/CDS/CSR/EDC/2000.4) Geneva: World Health Organization; 2000. pp. 1–54. [Google Scholar]

20. Clinical Laboratory of Standard Institute (CLSI) Performance standard for antimicrobial susceptibility testing for streptococci spp beta –hemolytic bacteria. 29th edition, CLSI guideline. CLSI Standard M100- Wayne. 2019;39(1):87–95. [Google Scholar]

21. Gheni AI. Detection of streptococci in the throat swabs from upper respiratory tract infections in Kurdistan region. J Life Sci. 2014;8(3):283–289. [Google Scholar]

22. Cheesbrough, M. District laboratory practice in tropical countries. part 2, second edtion. 3 chapters. Cambridge Uuniversity Press; 2006. p. 31-45. https://books.google.com.et/books?hl=en&lr=&id=Yjv-n5u6S7gC&oi=fnd&pg=PA1&ots=GEoMxt5Jsu&sig=qdgaLv5dqClpY7I-zbUeefRUvG4&redir_esc=y#v=onepage&q&f=false.

23. Daum L, Worthy SA, Yim KC, Nogueras M, Schuman R, Choi Y, Fischer GW. A clinical specimen collection and transport medium for molecular diagnostic and genomic applications. Epidemiol Infect. 2011;139(11):1764–1773. [PubMed] [Google Scholar]

24. Grivea IN, Syrogiannopoulos GA, Michoula AN, Gazeti G, Malli E, Tsilipounidaki K, Petinaki E. emm Types and clusters and macrolide resistance of pediatric group A streptococcal isolates in Central Greece during 2011–2017. PloS one. 2020;15(5):e0232777. [PMC free article] [PubMed] [Google Scholar]

25. Patel C, Green BD, Batt JM, Kholmurodova F, Barnes M, Geyer WJ, Benson J. Antibiotic prescribing for tonsillopharyngitis in a general practice setting: can the use of modified centor criteria reduce antibiotic prescribing? Aust J Gen Pract. 2019;48(6):395–401. [PubMed] [Google Scholar]

26. Igarashi H, Nago N, Kiyokawa H, f*ckushi M. Abdominal pain and nausea in the diagnosis of streptococcal pharyngitis in boys. Int J Gen Med. 2017;10:311–318. [PMC free article] [PubMed] [Google Scholar]

27. Malino IY, Utama DL, Soenarto Y. McIsaac criteria for diagnosis of acute group-a β-hemolytic streptococcal pharyngitis. Paediatr Indones. 2013;53(5):258–263. [Google Scholar]

28. Rijal K, Dhakal N, Shah R, Timilsina S, Mahato P, Thapa S, Ghimire P. Antibiotic susceptibility of group a Streptococcus isolated from throat swab culture of school children in Pokhara, Nepal. Nepal Med Coll J. 2009;11(4):238–240. [PubMed] [Google Scholar]

29. Gutiérrez-Jiménez J, Mendoza-Orozco MI, Vicente-Serrano A, Luna-Cazáres LM, Feliciano-Guzmán JM, Girón-Hernández JA, Vidal JE. Virulence genes and resistance to antibiotics of beta-hemolytic streptococci isolated from children in Chiapas, Mexico. J Infect Dev Ctries. 2018;12(02):80–88. [PubMed] [Google Scholar]

30. Alexandre M, Wang’ondu R, Cooney LM., Jr Focus: infectious diseases: group a streptococcal bacteremia following streptococcal pharyngitis in an older patient with diabetes: a case report. Yale J Biol Med. 2017;90(2):337–340. [PMC free article] [PubMed] [Google Scholar]

31. Bobia AA, Blaj OA, Oancea D, Iulia-Cristina B, Radu-Vasile B, Delia-Ioana H, Ciuca I. The prevalence of beta hemolytic Streptococcus in a Children’s Tertiary Care Hospital in Timisoara. Central Eur J Clin Res. 2019;2(1):73–78. [Google Scholar]

32. Khosravi AD, Ebrahimifard N, Shamsizadeh A, Shoja S. Isolation of Streptococcus pyogenes from children with pharyngitis and emm type analysis. J Chin Med Assoc. 2016;79(5):276–280. [PubMed] [Google Scholar]

33. Ashgar SS, Johargy A, Mukhtar M, Saati A. Prevalence of Streptococcus pyogenes among pre-school children ages 4 to 6 in Makah city, Saudi Arabia. Med Sci Healthc J. 2015;10(6):2–18. [Google Scholar]

34. Shaikh N, Leonard E, Martin JM. Prevalence of streptococcal pharyngitis and streptococcal carriage in children: a meta-analysis. Pediatrics. 2010;126(3):e557–e564. [PubMed] [Google Scholar]

35. Tartof SY, Reis JN, Andrade AN, Ramos RT, Reis MG, Riley LW. Factors associated with group a Streptococcus emm type diversification in a large urban setting in Brazil: a cross-sectional study. BMC Infect Dis. 2010;10(1):327. [PMC free article] [PubMed] [Google Scholar]

36. Ali AA, Khater WS, El Gendy YG. Erythromycin resistance in Streptococcus Pyogenes causing pharyngotonsillitis in Egyptian children and its association with the presence of fibronectin binding protein F1 (prtf1) gene. Egypt Jo Med Microbiol. 2016;38(79):1–8. [Google Scholar]

37. Engel ME, Cohen K, Gounden R, Kengne AP, Barth DD, Whitelaw AC, Dale JB. The Cape Town clinical decision rule for streptococcal pharyngitis in children. Pediatr Infect Dis J. 2017;36(3):250–255. [PMC free article] [PubMed] [Google Scholar]

38. Madeira G, Chicavel D, Munguambe A, Langa J, Mocumbi A. Streptococcal pharyngitis in children with painful throat: missed opportunities for rheumatic heart disease prevention in endemic area of Africa. Cardiovasc Diagn Ther. 2017;7(4):421. [PMC free article] [PubMed] [Google Scholar]

39. Kunga . Doctoral Dissertation, University of Nairobi. 2018. Prevalence and antibiotic susceptibility pattern of group a streptococcus in children with acute pharyngitis; pp. 1–59. [Google Scholar]

40. Sayyahfar S, Fahimzad A, Naddaf A, Tavassoli S. Antibiotic susceptibility evaluation of group A streptococcus isolated from children with pharyngitis: a study from Iran. Infect Chemother. 2015;47(4):225–230. [PMC free article] [PubMed] [Google Scholar]

41. Chazan B, Raz R, Edelstein H, Kennes Y, Gal V, Colodner R. Susceptibility of group A streptococcus to antimicrobial agents in northern Israel: a surveillance study. Microb Drug Resist. 2015;21(5):551–555. [PubMed] [Google Scholar]

42. Bilal M, Zahid M, Aslam Z, Khalid A. Prevalence of Group A beta-haemolytic Streptococcus pharyngitis and drug resistance in community-acquired pharyngitis in Pakistan. Elixir Int J. 2015;89:36831–36834. [Google Scholar]

43. Kumar AS. Is group a b-haemolytic streptococcus prevalent among the children with tonsillo-pharyngitis? A school health survey based study in Pondicherry. J Evid Based Med Health Care. 2017;44(5):217–220. [Google Scholar]

44. Nandi S, Kumar R, Ray P, Vohra H, Ganguly NK. Group A streptococcal sore throat in a periurban population of northern India: a one-year prospective study. Bull World Health Organ. 2001;79(6):528–533. [PMC free article] [PubMed] [Google Scholar]

45. Espadas-Maciá D, Macián EMF, Borrás R, Gisbert SP, Bonet JIM. Streptococcus pyogenes infection in paediatrics: from pharyngotonsillitis to invasive infections. Anales Pediatr (English Edition) 2018;88(2):75–81. [PubMed] [Google Scholar]

46. Abd El-Ghany SM, Abdelmaksoud AA, Saber SM, Abd El Hamid DH. Group A beta-hemolytic streptococcal pharyngitis and carriage rate among Egyptian children: a case-control study. Ann Saudi Med. 2015;35(5):377–382. [PMC free article] [PubMed] [Google Scholar]

47. Kaplan EL, Chhatwal GS, Rohde M. Reduced ability of penicillin to eradicate ingested group a streptococci from epithelial cells: clinical and pathogenetic implications. Clin Infect Dis. 2006;43(11):1398–1406. [PubMed] [Google Scholar]

48. Ogawa T, Terao Y, Okuni H, Ninomiya K, Sakata H, Ikebe K, Maeda Y, Kawabata S. Biofilm formation or internalization into epithelial cells enable Streptococcus pyogenes to evade antibiotic eradication in patients with pharyngitis. Microbiol Pathog. 2011;51(1–2):58–68. [PubMed] [Google Scholar]

49. Brook I, Gober AE. Failure to eradicate streptococci and beta lactamase producing bacteria. Acta Paediatr. 2008;97(2):193–195. [PubMed] [Google Scholar]

50. Brook I. Penicillin failure in the treatment of streptococcal pharyngo-tonsillitis. Curr Infect Dis Rep. 2013;15(3):232–235. [PubMed] [Google Scholar]

51. Berwal A, Chawla K, Shetty S, Gupta A. Trend of antibiotic susceptibility of Streptococcus pyogenes isolated from respiratory tract infections in tertiary care hospital in South Karnataka. Iran J Microbiol. 2019;11(1):13–18. [PMC free article] [PubMed] [Google Scholar]

52. Clancy J, Petitpas J, Dib-Hajj F, Yuan W, Cronan M, Kamath AV, Bergeron J, Retsema JA. Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes. Mol Microbiol. 1996;22(5):867–879. [PubMed] [Google Scholar]

53. Richter SS, Heilmann KP, Beekmann SE, Miller NJ, Miller AL, Rice CL, Doern CD, Reid SD, Doern GV. Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003. Clin Infect Dis. 2005;41(5):599–608. [PubMed] [Google Scholar]

54. Chopra I, Roberts M. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev. 2001;65(2):232–260. [PMC free article] [PubMed] [Google Scholar]

55. Bhalla K, Bhardwaj P, Gupta A, Mehra S, Nehra D, Nanda S. Role of epidemiological risk factors in improving the clinical diagnosis of streptococcal sore throat in pediatric clinical practice. J Fam Med Prim Care. 2019;8(10):3130–3135. [PMC free article] [PubMed] [Google Scholar]

56. Ba-Saddik I, Munibari A, Alhilali A, Ismail S, Murshed F, Coulter J, Parry C. Prevalence of group A beta-haemolytic Streptococcus isolated from children with acute pharyngotonsillitis in Aden, Yemen. Trop Med Int Health. 2014;19(4):431–439. [PubMed] [Google Scholar]

57. Rimoin AW, Fischer Walker CL, Chitale RA, Hamza HS, Vince A, Gardovska D, da Cunha AL, Qazi S, Steinhoffb MC. Variation in clinical presentation of childhood group a streptococcal pharyngitis in four countries. J Trop Pediatr. 2008;54(5):308–312. [PubMed] [Google Scholar]

Articles from BMC Microbiology are provided here courtesy of BMC

Prevalence and antibiotics susceptibility profiles of Streptococcus pyogenes among pediatric patients with acute pharyngitis at Felege Hiwot Comprehensive Specialized Hospital, Northwest Ethiopia (2024)
Top Articles
Latest Posts
Article information

Author: Jonah Leffler

Last Updated:

Views: 6221

Rating: 4.4 / 5 (45 voted)

Reviews: 92% of readers found this page helpful

Author information

Name: Jonah Leffler

Birthday: 1997-10-27

Address: 8987 Kieth Ports, Luettgenland, CT 54657-9808

Phone: +2611128251586

Job: Mining Supervisor

Hobby: Worldbuilding, Electronics, Amateur radio, Skiing, Cycling, Jogging, Taxidermy

Introduction: My name is Jonah Leffler, I am a determined, faithful, outstanding, inexpensive, cheerful, determined, smiling person who loves writing and wants to share my knowledge and understanding with you.